Search Results 441-450 of 15982 for melatonin receptor agonists
Ian Parney, M.D., Ph.D., Neurosurgery, Mayo Clinic: In some cases, this is something to manage the metastatic brain tumor burden for patients but isn't ...
Subjects who have taken or are currently taking any parenteral, inhaled, or oral prostacyclin or IP receptor agonists (e.g., epoprostenol, treprostinil ...
Unstable dose of SGLT-2 inhibitor, GLP-1 receptor agonist, or other adjuvant medication or starting a new glucose lowering agent during the trial. Unstable ...
The purpose of this study is to combine robust clinical data (e.g., prior chemotherapy or radiation exposure, cumulative Peptide Receptor Radionuclide ...
The purpose of this study is to to determine the individual treatment effect of somatostatin and whether duration of antibiotic therapy coupled with octreotide ...
The purpose of this study is to ensure technical success in the treatment of assessing diaphragmatic neuromuscular junction (NMJ) function of the diaphragm in ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to develop educational materials that will help patients and clinicians talk about treatment options for patients with advanced ...
Memantine hydrochloride may enhance cognitive function by binding to and inhibiting channels of receptors located in the central nervous system. Radiation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.